| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD005045.PUB2 |
| P8608 | Fatcat ID | release_aomt2sx4cvdxzmxe6rfulikesy |
| P698 | PubMed publication ID | 18254068 |
| P50 | author | Giovanni Meola | Q42696154 |
| Marta Panzeri | Q57093835 | ||
| P2093 | author name string | Michael R Rose | |
| Thera Links | |||
| Valeria Sansone | |||
| P2860 | cites work | Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome | Q24291252 |
| Identification of a mutation in the gene causing hyperkalemic periodic paralysis | Q24314688 | ||
| Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel | Q24337722 | ||
| Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) | Q24553132 | ||
| Linkage of atypical myotonia congenita to a sodium channel locus | Q28208789 | ||
| A calcium channel mutation causing hypokalemic periodic paralysis | Q28242375 | ||
| Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene | Q28242463 | ||
| Dihydropyridine receptor mutations cause hypokalemic periodic paralysis | Q28243593 | ||
| Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis | Q28246479 | ||
| A novel SCN4A mutation causing myotonia aggravated by cold and potassium | Q28256356 | ||
| Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity | Q28264796 | ||
| A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis | Q28305953 | ||
| Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis | Q28368180 | ||
| Improvement of muscle strength in familial hypokalaemic periodic paralysis with acetazolamide | Q33630951 | ||
| Therapy in myotonic disorders and in muscle channelopathies. | Q34267333 | ||
| Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features | Q34333434 | ||
| Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current | Q35208537 | ||
| Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). | Q36318487 | ||
| Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol | Q39367186 | ||
| Multiple anomalies, hypokalaemic paralysis and partial symptomatic relief by terbutaline. | Q39447227 | ||
| Defective Potassium Channel Kir2.1 Trafficking Underlies Andersen-Tawil Syndrome | Q40629496 | ||
| Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis | Q40780362 | ||
| Familial hypokalaemic periodic paralysis: prevention of paralytic attacks with lithium gluconate | Q41595107 | ||
| Hypokalemic periodic paralysis exacerbated by acetazolamide | Q42262712 | ||
| Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. | Q43608348 | ||
| Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome | Q44102576 | ||
| Acetazolamide Prophylaxis in Hypokalemic Periodic Paralysis | Q44944724 | ||
| beta-Adrenergic treatment of hyperkalemic periodic paralysis | Q45042912 | ||
| Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects | Q48842234 | ||
| Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis. | Q51850561 | ||
| Andersen's syndrome: A distinct periodic paralysis | Q57085845 | ||
| Hypokalemic periodic paralysis with unusual responses to acetazolamide and sympathomimetics | Q69475312 | ||
| Myotonic Periodic Paralysis Improved by Negative Sodium Balance | Q69536926 | ||
| The exercise test in periodic paralysis | Q69670928 | ||
| Acute effects of acetazolamide in hyperkalemic periodic paralysis | Q70155215 | ||
| Intravenous treatment of hypokalemic periodic paralysis | Q70447246 | ||
| Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness | Q71474790 | ||
| Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis | Q71747006 | ||
| Normal insulin release during sustained hyperglycaemia in hypokalaemic periodic paralysis: role of the potassium channel opener pinacidil in impaired muscle strength | Q71832047 | ||
| Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families | Q72017458 | ||
| Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects | Q72470409 | ||
| The calcium channel blocker verapamil in hypokalemic periodic paralysis | Q77407681 | ||
| Beta-adrenergic treatment of hyperkalemic periodic paralysis | Q93651189 | ||
| P921 | main subject | periodic paralysis | Q1788314 |
| P577 | publication date | 2008-01-23 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Treatment for periodic paralysis |
| Q35606217 | Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype |
| Q28082428 | Channelopathies of skeletal muscle excitability |
| Q64273247 | Clinical and Etiological Spectrum of Hypokalemic Periodic Paralysis in a Tertiary Care Hospital in Pakistan |
| Q38760046 | Dichlorphenamide: A Review in Primary Periodic Paralyses |
| Q58327238 | Gating Pore Currents in Sodium Channels |
| Q34523030 | Muscle channelopathies: the nondystrophic myotonias and periodic paralyses |
| Q53961929 | Persisting fatigue and myalgia as the presenting features in a case of hypokalaemic periodic paralysis. |
| Q36796484 | Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. |
| Q45957826 | Review of the Diagnosis and Treatment of Periodic Paralysis. |
| Q57811084 | Skeletal Muscle Channelopathies |
| Q37390029 | Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias |
| Q38698910 | Skeletal muscle na channel disorders |
| Q42975046 | The large-conductance calcium-activated potassium channel holds the key to the conundrum of familial hypokalemic periodic paralysis |
| Q36774714 | The nondystrophic myotonias |
| Q64050095 | Treatment and management of neuromuscular channelopathies |
| Q83835659 | [Muscle channelopathies. Myotonias and periodic paralyses] |
Search more.